Clinical Trials for Homozygous Familial Hypercholesterolemia

Find clinical trials for homozygous familial hypercholesterolemia. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

NCT ID: NCT07037771

This clinical trial is testing a new medicine called zodasiran to see if it helps people aged 12 and older who have a rare inherited condition called Homozygous Familial Hypercholesterolemia (HoFH)...

Recruiting

Phase: PHASE3 Type: interventional Locations: Cincinnati, Ohio, United States

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

NCT ID: NCT06723652

This clinical trial is studying a new treatment called SHR-1918 for patients with a rare genetic condition known as homozygous familial hypercholesterolemia (HoFH), which causes very high levels of...

Recruiting

Phase: PHASE3 Type: interventional Locations: Changsha, Hunan, China

HoFH, the International Clinical Collaborators Registry

NCT ID: NCT04815005

This clinical trial, called the HoFH International Clinical Collaborators Registry, is focused on a rare genetic condition known as homozygous familial hypercholesterolemia (HoFH). This condition l...

Recruiting

Type: observational Locations: Philadelphia, Pennsylvania, United States, Amsterdam, , Netherlands +2 more

NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia

NCT ID: NCT06125847

This clinical trial is investigating a new gene therapy called NGGT006, designed to help patients with a rare genetic condition known as homozygous familial hypercholesterolemia (HoFH). This condit...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Xi'an, Shaanxi, China

The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository

NCT ID: NCT01109368

The Rogosin Institute is conducting a study to create a special database for people with a rare genetic condition called homozygous familial hypercholesterolemia (hoFH), which causes extremely high...

Recruiting

Type: observational Locations: New York, New York, United States

LOWER: Lomitapide Observational Worldwide Evaluation Registry

NCT ID: NCT02135705

The LOWER study is looking at the long-term safety and effectiveness of a medication called lomitapide for patients with a rare genetic condition known as Homozygous Familial Hypercholesterolemia, ...

Recruiting

Type: observational Locations: Milwaukee, Wisconsin, United States, Los Angeles, California, United States +72 more

Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

NCT ID: NCT06009393

This clinical trial is studying a new medication called SHR-1918 to see how well it can lower a type of bad cholesterol known as LDL-C in patients with a condition called homozygous familial hyperc...

Not yet recruiting

Phase: PHASE2 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions